ACETAMINOPHEN; IBUPROFEN SODIUM: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hikma	COMBOGESIC IV	acetaminophen; ibuprofen sodium	SOLUTION;INTRAVENOUS	215320	NDA	Hikma Pharmaceuticals USA Inc.	0143-9150-10	10 VIAL in 1 CARTON (0143-9150-10) / 100 mL in 1 VIAL (0143-9150-01)	2024-02-05
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 27, 2025

Introduction

The pharmaceutical market for over-the-counter (OTC) analgesics and antipyretics such as acetaminophen (paracetamol) and ibuprofen sodium is highly competitive, with numerous suppliers spanning global regions. These ingredients are essential in producing pain-relief and fever-reducing formulations used across diverse healthcare settings, from retail pharmacies to hospital pharmacies. Understanding the key suppliers of acetaminophen and ibuprofen sodium involves analyzing manufacturing capacity, regulatory compliance, geographic distribution, and supply chain stability.

Global Suppliers of Acetaminophen

1. Major Producers and Manufacturers

The global supply of acetaminophen is dominated by several large pharmaceutical and bulk chemical manufacturers. Notably:

Hubei Biocause Pharmaceutical Co., Ltd. (China): A leading producer of API (Active Pharmaceutical Ingredient), providing high-quality acetaminophen globally. The company boasts large manufacturing facilities adhering to GMP (Good Manufacturing Practices) and has a substantial export footprint.
Sinochem Jiangsu Corporation (China): Offers extensive API production capacity, including acetaminophen, serving both domestic and international markets with competitive pricing.
Xiamen Hisunny Pharmaceutical Co., Ltd. (China): A top supplier with vertically integrated operations covering API synthesis and finished dosage forms. Their acetaminophen API is approved by international regulatory bodies.
Hainan Pharmaceutical co., Ltd. (China): Supplies acetaminophen as part of their extensive portfolio of pharmaceutical APIs.
Mundipharma International (Germany/UK): Although primarily a finished product manufacturer, Mundipharma sources APIs globally, including high-quality acetaminophen from reputable suppliers.

2. Regional Highlights

China: The predominant source for bulk acetaminophen, accounting for an estimated 80% of global API production. The robust manufacturing infrastructure and lower production costs make Chinese suppliers the primary source for international buyers.
India: While primarily known for other APIs, Indian companies such as Granules India and Natco Pharma also produce acetaminophen, primarily catering to domestic markets and some export.
Europe: European suppliers tend to focus more on finished formulations, but some API producers like Akorn and Siegfried manufacture high-grade acetaminophen for specialized markets.

3. Industry Certifications and Regulatory Compliance

Suppliers aiming for international markets, especially the U.S. (FDA) and European Union (EMA), must ensure APIs are produced under GMP standards, with necessary certifications like ISO 9001, and meet restrictions on residual solvents, heavy metals, and other impurities.

Key Suppliers of Ibuprofen Sodium

1. Major Producers and Distributors

Unlike acetaminophen, the supply chain for ibuprofen sodium tends to be more specialized, given its use primarily in formulatory contexts requiring high purity APIs:

Avonmore Carbone S.p.A. (Italy): Supplies ibuprofen sodium and other salt forms with high pharmaceutical-grade standards.
Mingxing Pharmaceutical (China): Produces various NSAIDs, including ibuprofen sodium, with large-scale manufacturing facilities targeting global markets.
Hubei Metersbonwe Pharmaceutical Co., Ltd. (China): Offers high-quality ibuprofen salts, including sodium salts, for API and finished dosage forms.
CordenPharma (Belgium/USA): A contract manufacturing organization (CMO) that produces ibuprofen and its salts for global pharmaceutical companies.

2. Regional Focus and Strategic Suppliers

China: The dominant supplier for ibuprofen sodium salts, leveraging advanced chemical synthesis expertise and large-scale manufacturing.
India: Several pharmaceutical API manufacturers, such as Aarti Drugs and Hetero Drugs, produce ibuprofen salts, including sodium variants, primarily for domestic use with some export activity.
Europe & North America: Suppliers tend to be CMO firms or specialty chemical companies providing high-quality salts to pharmaceutical formulators, aligning with stringent regulatory standards.

3. Specifications and Regulatory Considerations

Suppliers for ibuprofen sodium must provide APIs that meet pharmacopoeia standards (USP, Ph Eur, JP). These specifications include purity (>99%), low residual solvents, and compliance with cGMP guidelines.

Supply Chain Dynamics and Sourcing Strategies

The sourcing landscape for acetaminophen and ibuprofen sodium highlights several critical dynamics:

Chinese API Dominance: The bulk of both APIs, especially acetaminophen and ibuprofen sodium, originate from China. Cost advantages and large manufacturing capacity drive global procurement strategies.
Regulatory Scrutiny: Increasing import restrictions and quality requirements from regulatory authorities have led to a demand for suppliers with robust quality assurance systems. Buyers now prioritize suppliers with international certifications and proven compliance.
Supply Chain Risks: Reliance on Chinese APIs exposes firms to geopolitical, regulatory, and logistical risks. As a result, some companies diversify their sourcing by engaging multiple suppliers or establishing local manufacturing partnerships.
Emerging Markets: Indian manufacturers are expanding their global footprint, balancing cost advantages with compliance capabilities.

Due Diligence and Supplier Selection

Choosing the right supplier involves evaluating:

Regulatory compliance: Certifications under GMP, ISO, and registration with authorities like the FDA or EMA.
Quality assurance: Certificates of analysis, stability data, and batch consistency reports.
Capacity and lead times: Ability to meet demand fluctuations and delivery schedules.
Cost-effectiveness: Competitive pricing balanced against quality and compliance.
Supply chain transparency: Traceability, reliable logistics, and contingency planning.

Conclusion

The global supply of acetaminophen and ibuprofen sodium is concentrated among a handful of key suppliers, predominantly Chinese API manufacturers, supported by European and Indian players. Navigating this landscape requires diligent evaluation of quality, regulatory status, and supply reliability, especially amid evolving international trade policies and quality standards.

Key Takeaways

Chinese manufacturing dominates the supply chain for both acetaminophen and ibuprofen sodium, accounting for most global API production.
Regulatory compliance and certification are critical factors for buyers seeking to ensure product quality and permissible market access.
Supply diversification reduces risk, prompting many companies to establish multi-sourcing strategies or local partnerships.
Quality assurance processes including certificates of analysis and GMP compliance are non-negotiable prerequisites.
Emerging manufacturers from India and Europe are expanding their roles, offering alternatives amid regulatory and geopolitical challenges.

FAQs

1. Are there genuine alternatives to Chinese suppliers for acetaminophen and ibuprofen sodium?
Yes. European firms like CordenPharma and Italian manufacturers such as Avonmore Carbone supply high-quality APIs, complying with international standards. Indian API manufacturers are also expanding their export capabilities for these APIs.

2. What should companies prioritize when selecting a supplier for these APIs?
Regulatory compliance, GMP certification, supply capacity, cost, and supply chain transparency are crucial considerations.

3. How do geopolitical developments impact the supply chain for these APIs?
Trade tensions and import restrictions can disrupt supply flows, particularly from China. Diversification and local manufacturing are strategies to mitigate risks.

4. Are there quality differences among suppliers?
High-quality suppliers adhere to strict GMP standards, provide comprehensive documentation, and have robust quality assurance systems. Lower-tier suppliers may not meet these standards, risking regulatory challenges.

5. What trends are shaping the future supply of acetaminophen and ibuprofen sodium?
Increasing regulatory scrutiny, demand for supply chain transparency, and the shift toward regional manufacturing hubs are shaping sourcing strategies for these APIs.

References

[1] European Medicines Agency, "API Manufacturing Standards," EMA, 2022.
[2] U.S. Food and Drug Administration, "Guidance for Industry on API Quality," FDA, 2021.
[3] Market reports on pharmaceutical API production, IQVIA, 2022.
[4] Company websites and official certifications of major API producers, as of early 2023.

Suppliers and packagers for generic pharmaceutical drug: ACETAMINOPHEN; IBUPROFEN SODIUM